Colony Stimulating Factors Market
完整報告名稱與涵蓋範圍
Colony Stimulating Factors Market Size, Share & Trends Analysis Report By Type, By Application, By Drug, By Dosage, By Route of administration, By Distribution Channel, By End-User, By Region, And By Segment Forecasts, 2024-2031
報告摘要
The Colony Stimulating Factors Market is positioned for steady expansion, with a projected CAGR of 7.90% from 2024 to 2031.
The Colony Stimulating Factors sector involves proteins that resemble hormones and encourage the development of immune cells that can fight infections. This domain has witnessed meaningful transformation owing to technological breakthroughs and shifting healthcare dynamics.
Market momentum is bolstered by rising requirement advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, bolstered by rapid industrialization and expanding end-user bases.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Colony Stimulating Factors Market Snapshot
Chapter 4. Global Colony Stimulating Factors Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Product Type Estimates & Trend Analysis
5.1. by Product Type & Market Share, 2023 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Product Type:
5.2.1. Macrophage–Colony-Stimulating Factor (M-CSF)
5.2.2. Multiple-Colony-Stimulating Factor or Interleukin 3 (IL-3)
5.2.3. Granulocyte-Macrophage–Colony-Stimulating Factor (GM-CSF)
5.2.4. Granulocyte–Colony-Stimulating Factor (G-CSF)
Chapter 6. Market Segmentation 2: by Drug Estimates & Trend Analysis
6.1. by Drug & Market Share, 2023 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Drug:
6.2.1. Pegfilgrastim
6.2.2. Tbo-filgrastim
6.2.3. Sargramostim
6.2.4. Filgrastim
Chapter 7. Market Segmentation 3: by Application Estimates & Trend Analysis
7.1. by Application & Market Share, 2023 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:
7.2.1. Aplastic Anemia
7.2.2. Bone Marrow Transplantation
7.2.3. Neutropenia
7.2.4. Neutropenia Associated with Chemotherapy
7.2.5. Neutropenia Associated with Radiation
7.2.6. Peripheral Progenitor Cell Transplantations
Chapter 8. Market Segmentation 4: by Dosage Estimates & Trend Analysis
8.1. by Dosage & Market Share, 2023 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Dosage:
8.2.1. Injection
8.2.2. Tablets
8.2.3. Capsule
8.2.4. Others
Chapter 9. Market Segmentation 5: by Route of Administration Estimates & Trend Analysis
9.1. by Route of Administration & Market Share, 2023 & 2031
9.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Route of Administration:
9.2.1. Intravenous
9.2.2. Subcutaneous
9.2.3. Oral
9.2.4. Others
Chapter 10. Market Segmentation 6: by End-users Estimates & Trend Analysis
10.1. by End-users & Market Share, 2023 & 2031
10.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End-users:
10.2.1. Hospitals
10.2.2. Specialty Clinics
10.2.3. Homecare
10.2.4. Others
Chapter 11. Colony Stimulating Factors Market Segmentation 7: Regional Estimates & Trend Analysis
11.1. North America
11.1.1. North America Colony Stimulating Factors Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
11.1.2. North America Colony Stimulating Factors Market Revenue (US$ Million) Estimates and Forecasts by Drug, 2024-2031
11.1.3. North America Colony Stimulating Factors Market revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
11.1.4. North America Colony Stimulating Factors Market revenue (US$ Million) Estimates and Forecasts by Dosage, 2024-2031
11.1.5. North America Colony Stimulating Factors Market revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2024-2031
11.1.6. North America Colony Stimulating Factors Market revenue (US$ Million) Estimates and Forecasts by End-users, 2024-2031
11.1.7. North America Colony Stimulating Factors Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
11.2. Europe
11.2.1. Europe Colony Stimulating Factors Market revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
11.2.2. Europe Colony Stimulating Factors Market revenue (US$ Million) Estimates and Forecasts by Drug, 2024-2031
11.2.3. Europe Colony Stimulating Factors Market revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
11.2.4. Europe Colony Stimulating Factors Market revenue (US$ Million) Estimates and Forecasts by Dosage, 2024-2031
11.2.5. Europe Colony Stimulating Factors Market revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2024-2031
11.2.6. Europe Colony Stimulating Factors Market revenue (US$ Million) Estimates and Forecasts by End-users, 2024-2031
11.2.7. Europe Colony Stimulating Factors Market revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
11.3. Asia Pacific
11.3.1. Asia Pacific Colony Stimulating Factors Market revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
11.3.2. Asia Pacific Colony Stimulating Factors Market revenue (US$ Million) Estimates and Forecasts by Drug, 2024-2031
11.3.3. Asia-Pacific Colony Stimulating Factors Market revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
11.3.4. Asia Pacific Colony Stimulating Factors Market revenue (US$ Million) Estimates and Forecasts by Dosage, 2024-2031
11.3.5. Asia Pacific Colony Stimulating Factors Market revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2024-2031
11.3.6. Asia Pacific Colony Stimulating Factors Market revenue (US$ Million) Estimates and Forecasts by End-users, 2024-2031
11.3.7. Asia Pacific Colony Stimulating Factors Market revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
11.4. Latin America
11.4.1. Latin America Colony Stimulating Factors Market revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
11.4.2. Latin America Colony Stimulating Factors Market revenue (US$ Million) Estimates and Forecasts by Drug, 2024-2031
11.4.3. Latin America Colony Stimulating Factors Market revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
11.4.4. Latin America Colony Stimulating Factors Market revenue (US$ Million) Estimates and Forecasts by Dosage, 2024-2031
11.4.5. Latin America Colony Stimulating Factors Market revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2024-2031
11.4.6. Latin America Colony Stimulating Factors Market revenue (US$ Million) Estimates and Forecasts by End-users, 2024-2031
11.4.7. Latin America Colony Stimulating Factors Market revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
11.5. Middle East & Africa
11.5.1. Middle East & Africa Colony Stimulating Factors Market revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
11.5.2. Middle East & Africa Colony Stimulating Factors Market revenue (US$ Million) Estimates and Forecasts by Drug, 2024-2031
11.5.3. Middle East & Africa Colony Stimulating Factors Market revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
11.5.4. Middle East & Africa Colony Stimulating Factors Market revenue (US$ Million) Estimates and Forecasts by Dosage, 2024-2031
11.5.5. Middle East & Africa Colony Stimulating Factors Market revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2024-2031
11.5.6. Middle East & Africa Colony Stimulating Factors Market revenue (US$ Million) Estimates and Forecasts by End-users, 2024-2031
11.5.7. Middle East & Africa Colony Stimulating Factors Market revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
Chapter 12. Competitive Landscape
12.1. Major Mergers and Acquisitions/Strategic Alliances
12.2. Company Profiles
12.2.1. Intas Pharmaceuticals Ltd.
12.2.2. Sanofi
12.2.3. Novartis AG
12.2.4. Teva Pharmaceutical Industries Ltd.
12.2.5. Pfizer, Inc.
12.2.6. GlaxoSmithKline plc
12.2.7. Biocon
12.2.8. Dr. Reddy's Laboratories Ltd.
12.2.9. Amgen Inc.
12.2.10. Merck KGaA
12.2.11. Takeda Pharmaceutical Company Limited
12.2.12. Thermo Fisher Scientific Inc.
12.2.13. Stada Arzneimittel AG
12.2.14. Emcure Pharmaceuticals Limited.
12.2.15. Celltrion, Inc
12.2.16. Biocad
12.2.17. Coherus BioSciences
12.2.18. Johnson & Johnson Private Limited
12.2.19. Eli Lilly and Company.
12.2.20. Abbott
12.2.21. Other Prominent Players
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們